The Exploration for Pharmacodynamics and Pharmacokinetic Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy Subjects

Trial Profile

The Exploration for Pharmacodynamics and Pharmacokinetic Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 31 May 2017

At a glance

  • Drugs YH 4808 (Primary) ; Amoxicillin; Clarithromycin; Esomeprazole
  • Indications Gastro-oesophageal reflux; NSAID-induced ulcer; Reflux oesophagitis
  • Focus Pharmacokinetics
  • Acronyms YH4808-108
  • Sponsors Yuhan
  • Most Recent Events

    • 31 May 2017 Last checked against Korean Clinical Trials Register
    • 16 Dec 2013 Actual study completion date changed from 1 Nov 2013 to 26 Nov 2013 as reported by Clinical Research Information Service (Cris)- Republic of Korea
    • 16 Dec 2013 Actual initiation date changed from 1 Jul 2013 to 25 Jul 2013 as reported by Clinical Research Information Service (Cris)- Republic of Korea
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top